Senior Systematic Reviewer
Zulian Liu is a senior systematic reviewer in the EBCTCG. Before joining the EBCTCG, she worked in various research capacities, undertaking systematic reviews, rapid evidence reviews and health technology assessments for UK regional and national organisations including the National Institute for Health and Care Excellence (NICE) and the National Institute for Health Research (NIHR) on a wide range of health topics and technologies. Prior to her UK academic career, Zulian worked as a paediatrician in China.
Trastuzumab for HER2-positive early stage breast cancer: a meta-analysis of individual patient data from 13,864 women from seven randomised trials
GRAY R. et al, (2021), The Lancet Oncology
Locoregional recurrence after neo-adjuvant chemotherapy (NACT) for early breast cancer: a literature review
Tyagi S. et al, (2020), BREAST CANCER RESEARCH AND TREATMENT, 180, 558 - 558
Increasing the dose intensity of chemotherapy by more frequent administration or sequential scheduling: a patient-level meta-analysis of 37 298 women with early breast cancer in 26 randomised trials.
Early Breast Cancer Trialists' Collaborative Group (EBCTCG) None., (2019), Lancet, 393, 1440 - 1452
Psychological interventions for coronary heart disease: Cochrane systematic review and meta-analysis.
Richards SH. et al, (2018), Eur J Prev Cardiol, 25, 247 - 259
Transcatheter aortic valve implantation for aortic stenosis in high surgical risk patients: A systematic review and meta-analysis.
Liu Z. et al, (2018), PLoS One, 13